Dr Truttmann is a proud generalist interested in aging, protein folding, genetics, and host-pathogen interactions. Following his training in microbiology at the Biocenter, University of Basel, Switzerland, Dr. Truttmann completed postdoctoral fellowships at the Whitehead Institute for Biomedical Research at MIT and Boston Children’s Hospital/Harvard Medical School. At Michigan, Dr. Truttmann’s research centers on the post-translational regulation of chaperone function in aging, aging-associated diseases, protein aggregation, and host cell infection. In addition, Dr. Truttmann’s lab maintains a strong interest in tool development, specializing in the de novo generation of single-chain antibody fragments, called nanobodies. With support from the Bay Area Lyme Foundation, the Truttmann lab will continue its development of novel anti-Borrelia spp. nanobodies as new diagnostic and therapeutic options for Lyme disease.